News / Korea / yonhap_finance
Nature Cell to Acquire Full Ownership of U.S. Subsidiary for 9.7 Billion Won
Health Technology · Biotechnology · yonhap_finance · 2026-08-26
007390
Nature Cell announced a 9.7 billion won investment to acquire additional shares in its U.S. subsidiary, securing a 100% stake to boost local operations.
What Happened
Equity Acquisition: KOSDAQ-listed Nature Cell has announced the acquisition of 700,000 additional shares in its U.S. subsidiary, Nature Cell America. This transaction, valued at approximately 9.7 billion won, will bring the company's ownership stake to 100%.
Strategic Intent: The primary objective of this investment is to facilitate business expansion within the U.S. market. Furthermore, the capital will be utilized to enhance production facilities for stem cell therapeutics.
Timeline: The acquisition is scheduled to be completed by the 8th of next month. This disclosure was generated based on official filing data provided by Yonhap Infomax.
Future Outlook: By consolidating full control over its American entity, Nature Cell aims to streamline its stem cell research and cosmetic product distribution. The move is expected to bolster the company's operational efficiency and market presence in the United States.